Brought to you by WBIW News and Network Indiana
Last updated on Tuesday, March 16, 2010
(INDIANAPOLIS, IN) - Eli Lilly has announced a new exclusive worldwide license agreement with an Australian Drug Development Company.
Lilly would receive the rights to commercialize Axiron, an experimental underarm testosterone solution created by Acrux, which is currently under regulatory review by the U.S. Food and Drug Administration.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.